Factors That Reduce Health-Related Quality of Life in Patients With Primary Sclerosing Cholangitis

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 7, 2012, Pages 769-775.e2

  Benito de Valle, Maria ^a   Rahman, Monira ^b   Lindkvist, Björn ^a   Björnsson, Einar ^a   Chapman, Roger ^b   Kalaitzakis, Evangelos ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Cholestatic liver disease; CLDQ; FIS; HAD

Indexed keywords

ALKALINE PHOSPHATASE;

ADULT; ANXIETY; ARTICLE; CORRELATION ANALYSIS; DEPRESSION; DISTRESS SYNDROME; FATIGUE; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRURITUS; QUALITY OF LIFE; SWEDEN; UNITED KINGDOM;

EID: 84862660401     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.01.025     Document Type: Article

References (29)

1. Younossi Z.M., Boparai N., Price L.L., et al. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol 2001, 96:2199-2205.
2. Afendy A., Kallman J.B., Stepanova M., et al. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther 2009, 30:469-476.
3. Häuser W., Holtmann G., Grandt D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol 2004, 2:157-163.
4. Gross C.R., Malinchoc M., Kim W.R., et al. Quality of life before and after liver transplantation for cholestatic liver disease. Hepatology 1999, 29:356-364.
5. Marchesini G., Bianchi G., Amodio P., et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001, 120:170-178.
6. Younossi Z.M., Kiwi M.L., Boparai N., et al. Cholestatic liver diseases and health-related quality of life. Am J Gastroenterol 2000, 95:497-502.
7. Björnsson E., Simren M., Olsson R., et al. Fatigue in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2004, 39:961-968.
8. Goldblatt J., Taylor P.J., Lipman T., et al. The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology 2002, 122:1235-1241.
9. Huet P.M., Deslauriers J., Tran A., et al. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 2000, 95:760-767.
10. Cauch-Dudek K., Abbey S., Stewart D.E., et al. Fatigue in primary biliary cirrhosis. Gut 1998, 43:705-710.
11. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
12. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36): I-conceptual framework and item selection. Med Care 1992, 30:473-483.
13. Sullivan M.K.J., Taft C., Ware J.E., et al. Health survey: Swedish manual and interpretation guide 2002, Sahlgrenska University Hospital, Gothenburg, Sweden. 2nd ed.
14. Kanwal F., Hays R.D., Kilbourne A.M., et al. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?. Am J Gastroenterol 2004, 99:1726-1732.
15. Younossi Z.M., Guyatt G., Kiwi M., et al. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999, 45:295-300.
16. Younossi Z.M., Boparai N., McCormick M., et al. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol 2001, 96:579-583.
17. Fisk J.D., Ritvo P.G., Ross L., et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994, 18(Suppl 1):S79-S83.
18. Prince M.I., James O.F., Holland N.P., et al. Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol 2000, 32:368-373.
19. Björnsson E., Simren M., Olsson R., et al. Fatigue is not a specific symptom in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2005, 17:351-357.
20. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
21. Lisspers J., Nygren A., Söderman E. Hospital anxiety and depression scale (HAD): some psychometric data for a Swedish sample. Acta Psychiatr Scand 1997, 96:281-286.
22. Wyrwich K.W., Nienaber N.A., Tierney W.M., et al. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999, 37:469-478.
23. Ferguson R.J., Robinson A.B., Splaine M. Use of the reliable change index to evaluate clinical significance in SF-36 outcomes. Qual Life Res 2002, 11:509-516.
24. Björnsson E., Boberg K.M., Cullen S., et al. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut 2002, 51:731-735.
25. Swain M.G., Maric M. Defective corticotropin-releasing hormone mediated neuroendocrine and behavioral responses in cholestatic rats: implications for cholestatic liver disease-related sickness behaviors. Hepatology 1995, 22:1560-1564.
26. Zietz B., Lock G., Plach B., et al. Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis. Eur J Gastroenterol Hepatol 2003, 15:495-501.
27. van Os E., van den Broek W.W., Mulder P.G., et al. Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 2007, 46:1099-1103.
28. Bryant R.V., van Langenberg D.R., Holtmann G.J., et al. Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status. J Gastroenterol Hepatol 2011, 26:916-923.
29. Simrén M., Axelsson J., Gillberg R., et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002, 97:389-396.